Merck Target Raised to $155 as Shares Hit 52-Week High on Breakout
MRK•MRK•MRK•MRK•Merck's price target rose to $155 from $136 as analysts maintain an Outperform rating, while its average brokerage recommendation stands at 1.73 reflecting a strong Buy consensus. The stock hit a 52-week high of $129.69 and shows a bullish breakout with rising volume and higher swing lows.
Merck's price objective was lifted from $136 to $155 as analysts reaffirmed an Outperform stance, signaling expectations of stronger revenue growth from its pharmaceutical portfolio.
The average brokerage recommendation of 1.73 derives from 30 firms, including 18 Strong Buys, underscoring broad market optimism that helped drive shares to a new 52-week peak of $129.69.
Technical structure shows a bullish breakout from a pennant pattern, confirmed by above-average trading volume, rising swing lows, and momentum indicators pointing toward further upside potential.
Fxempire
